Manulife (Manufacturers Life Insurance)
IGMS

Manulife (Manufacturers Life Insurance)’s IGM Biosciences IGMS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-72,155
Closed -$441K – 2942
2024
Q4 		$441K Sell
72,155
-2,457
-3% -$29.2K ﹤0.01% 2297
2024
Q3 		$1.23M Buy
74,612
+5,683
+8% +$62.3K ﹤0.01% 1815
2024
Q2 		$474K Sell
68,929
-1,572
-2% -$13.5K ﹤0.01% 2241
2024
Q1 		$680K Buy
70,501
+21,559
+44% +$250K ﹤0.01% 2059
2023
Q4 		$407K Hold
48,942
– – ﹤0.01% 2264
2023
Q3 		$409K Hold
48,942
– – ﹤0.01% 2231
2023
Q2 		$452K Buy
48,942
+11,286
+30% +$126K ﹤0.01% 2107
2023
Q1 		$517K Hold
37,656
– – ﹤0.01% 1988
2022
Q4 		$614K Buy
37,656
+35
+0.1% +$700 ﹤0.01% 1852
2022
Q3 		$746K Sell
37,621
-161
-0.4% -$3.25K ﹤0.01% 1740
2022
Q2 		$695K Buy
37,782
+6,364
+20% +$113K ﹤0.01% 1825
2022
Q1 		$814K Buy
+31,418
New +$585K ﹤0.01% 1876
2021
Q4 		– Sell
-4,749
Closed -$312K – 3145
2021
Q3 		$312K Sell
4,749
-448
-9% -$34.3K ﹤0.01% 2640
2021
Q2 		$432K Buy
5,197
+499
+11% +$37K ﹤0.01% 2543
2021
Q1 		$360K Sell
4,698
-32
-0.7% -$2.91K ﹤0.01% 2494
2020
Q4 		$418K Buy
4,730
+4
+0.1% +$281 ﹤0.01% 2311
2020
Q3 		$349K Hold
4,726
– – ﹤0.01% 2189
2020
Q2 		$321K Buy
4,726
+952
+25% +$57.8K ﹤0.01% 2203
2020
Q1 		$212K Buy
+3,774
New +$165K ﹤0.01% 2292

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IGMS Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 72,155 shares — an estimated $441K sold.

Manulife (Manufacturers Life Insurance) first reported a position in IGMS in Q1 2020 and held it in 19 quarters. The position peaked at $1.23M in Q3 2024. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 72,155 IGM Biosciences shares in Q1 2025, an estimated $441K.
  • Manulife (Manufacturers Life Insurance) first reported a position in IGM Biosciences in Q1 2020 and held it in 19 quarters.
  • Manulife (Manufacturers Life Insurance)'s IGM Biosciences position peaked at $1.23M in Q3 2024.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.